3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
9
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, T-Cell
6
Lymphoma
6
Sezary Syndrome
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Malignant mesenchymal tumor
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
45
fludarabine
38
Whole-Body Irradiation
38
Mycophenolic Acid
37
Imatinib Mesylate
36
nilotinib
34
Tacrolimus
30
Busulfan
23
Cyclosporine
18
Melphalan
17
Granulocyte Colony-Stimulating Factor
17
Dasatinib
17
thymoglobulin
16
Methotrexate
16
Thiotepa
15
Peripheral Blood Stem Cell Transplantation
15
Antilymphocyte Serum
15
bosutinib
13
Filgrastim
13
Stem Cell Transplantation
11
sargramostim
8
ponatinib
8
Cytarabine
8
Cyclosporins
8
Cord Blood Stem Cell Transplantation
8
Clofarabine
8
Sirolimus
7
Rituximab
7
plerixafor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
romidepsin
×
Clear all
No trials found.